- Home
- THTX
as 12-18-2024 11:43am EST
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
| Founded: | 1993 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 54.3M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 85.1K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.07 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.08 - $2.58 | Next Earning Date: | 10-10-2024 |
| Revenue: | $84,316,000 | Revenue Growth: | 5.75% |
| Revenue Growth (this year): | 5.6% | Revenue Growth (next year): | 4.62% |
Latest Theratechnologies Inc. News
THTX Breaking Stock News: Dive into THTX Ticker-Specific Updates for Smart Investing
MT Newswires
8 days ago
Theratechnologies Receives March 2025 PDUFA Goal Date For Updated Tesamorelin F8 Formulation sBLA
MT Newswires
9 days ago
Theratechnologies Gets Medical Review Committee Approval for Higher Doses of TH1902 at Phase 1b Trial
GlobeNewswire
9 days ago
Theratechnologies Announces Preliminary Tolerability and Efficacy Data from Phase 1b, Dose-Ranging Trial of Sudocetaxel Zendusortide in Patients with Advanced Ovarian Cancer
TipRanks
13 days ago
Theratechnologies enters exclusive licensing agreement with Ionis
MT Newswires
14 days ago
Theratechnologies to Commercialize Two RNA-targeted Medicines in Canada
MT Newswires
14 days ago
Theratechnologies Acquires Canadian Rights to 2 RNA Medicines From Ionis Pharmaceuticals
GlobeNewswire
14 days ago
Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in Canada
MT Newswires
15 days ago
Theratechnologies Resumes Production of EGRIFTA SV
Compare THTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "THTX Theratechnologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.